Thursday , 27 October 2016
Home » News » Juvéderm Voluma Wins Approval By The FDA And Praise From The Wall Street Journal

Juvéderm Voluma Wins Approval By The FDA And Praise From The Wall Street Journal

You may have heard of Juvéderm Voluma, the all new uniquely formulated injectable gel filler designed to decrease the sagging of loose skin on the cheeks while increasing firmness and fullness. This product is the first of its kind to receive approval from the US Food & Drug Administration (FDA). An FDA Advisory Committee found that Juvéderm Voluma’s application was unique among applications for permission to administer cheek augmentation volume and fullness.


Because of the many unique qualities it possesses, this product was featured in Wall Street Journal article dated February 5, 2014. The article reported that Juvéderm Voluma had been found to be a safe, effective, long term, non-surgical anti-aging solution with results lasting as long as two years.

You will be happy to know that Juvéderm Voluma is a natural product made of hyaluronic acid. This is a substance that occurs naturally in well hydrated skin; however, as we age, production of this natural lubricant decreases. With this excellent product, you can simply replace that natural substance quickly, easily and fairly painlessly with no worries about recovery time from surgery. This is an easy and effective way to attain and maintain the firm, full, youthful appearance of your skin.

To read the full Wall Street Journal Article, visit: goo.gl/YNqbwB

Check Also

Smartclick System

Galderma’s Newly Launched Restylane Skinboosters Smart-Click System

After Winning The Coveted Red Dot Design Award, The Newly Launched Restylane Skinboosters Smart-Click System ...

Leave a Reply

Your email address will not be published. Required fields are marked *


*